Prostate Cancer - Results from #1620

Avoiding unnecessary biopsy: the combination of PRIMARY score with prostate-specific antigen density for prostate biopsy decision. January 4, 2024

Biochemical progression free and overall survival among Black men with stage IV prostate cancer in South Africa: Results from a prospective cohort study. January 4, 2024

Increasing Use of Shorter-Course Radiotherapy for Prostate Cancer. January 4, 2024

Quantifying Intrafraction Motion and the Impact of Gating for MRI-guided Stereotactic Radiotherapy for Prostate Cancer: Analysis of the MRI arm from the MIRAGE Phase III Randomized Trial. January 3, 2024

User-Centered Design and Usability of a Culturally Adapted Virtual Survivorship Care App for Chinese Canadian Prostate Cancer Survivors: Qualitative Descriptive Study. January 3, 2024

Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life. January 3, 2024

Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase January 3, 2024

The prognostic value of Eastern Cooperative Oncology Group performance status on overall survival among patients with metastatic prostate cancer: a systematic review and meta-analysis. January 3, 2024

Exploring the intratumoral heterogeneity of DNA ploidy in prostate cancer. January 2, 2024

Potential roles of FGF5 as a candidate therapeutic target in prostate cancer. January 2, 2024

In Vitro Prostate Cancer Treatment via CRISPR-Cas9 Gene Editing Facilitated by Polyethyleneimine-Derived Graphene Quantum Dots. January 2, 2024

Association of neighborhood gentrification with prostate cancer and immune markers in African American and European American men. January 2, 2024

FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer. January 2, 2024

Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy. January 2, 2024

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. January 2, 2024

The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study. January 1, 2024

The Association of County-level Prostate-specific Antigen Screening with Metastatic Prostate Cancer and Prostate Cancer Mortality. January 1, 2024

Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study. January 1, 2024

Heterogeneity of Radiological Progression Patterns and Association with Outcomes in Patients with Metastatic Prostate Cancer. January 1, 2024

Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years' Report from the EAU Robotic Urology Section Scientific Working Group. January 1, 2024

Page 82 of 1438